Home
| Subject Search
| Help
| Symbols Help
| Pre-Reg Help
| Final Exam Schedule
| My Selections
|
Searched for: 1 subject found.
20.102 Metakaryotic Stem Cells in Carcinogenesis: Origins and Cures
(
)
Not offered regularly; consult department
(Subject meets with 20.215)
Prereq: Biology (GIR), Calculus II (GIR), and Chemistry (GIR)
Units: 3-0-9![]()
Metakaryotic stem cells of organogenesis, wound healing, and the pathogenic lesions of cancers and atherosclerotic plaques. Metakaryotic cell resistance to x-ray- and chemo-therapies. Common drug treatment protocols lethal to metakaryotic cancer stem cells in vivo first clinical trial against pancreatic cancer. Application of a hypermutable/mutator stem cell model to the age-specific mortality from clonal diseases, and the expected responses to metakaryocidal drugs in attempted cure and prevention of tumors or atherosclerotic plaques. Students taking 20.215 responsible for de novo computer modeling.
W. Thilly